iiinova — where your digital self keeps evolving

Reposted by Vicky Bennett

Amprologix @amprologix.bsky.social · 16/07/2025

We're proud to announce that Amprologix is one of the 103 finalists selected to participate in the MassChallenge Switzerland & UK Accelerator Programme 2025, chosen from a pool of 1,527 high-potential startups worldwide.

amprologix.com

Amprologix Selected for MassChallenge Switzerland & UK 2025 Accelerator - Amprologix

Amprologix joins a global network of innovators We're proud to announce that Amprologix is one of the 103 finalists selected to participate in the MassChallenge Switzerland & UK Accelerator Programme ...

001

Reposted by Vicky Bennett

Amprologix @amprologix.bsky.social · 16/06/2025

Epidermicin NI01, has been featured in EMJ Reviews following a presentation by CSO @matupton.bsky.social at @escmid.bsky.social Global 2025. The data highlights efficacy in MRSA wound infections, and low risk of triggering allergic reactions - a promising step forward in the fight against AMR.

emjreviews.com

Epidermicin NI01, a First-in-Class Peptide Antibiotic Candidate, Has Potent Efficacy in a Robust MRSA Wound Infection Model and Low Allergic Reaction Liabilities

Over 10% of antibiotic prescriptions are for skin infections.1,2 New therapeutic approaches are required, and new modalities may be...

022

Reposted by Vicky Bennett

Amprologix @amprologix.bsky.social · 21/05/2025

@matupton.bsky.social, CSO, recently presented results from ongoing research at ESCMID Global 2025 - the Congress of the European Society of Clinical Microbiology and Infectious Diseases - in Vienna www.plymouth.ac.uk/news/studies...

plymouth.ac.uk

Studies shows new class of antibiotic is effective in tackling MRSA

University of Plymouth news: The latest results of ongoing research by the University, and spinout company Amprologix, will be presented to leading...

031

Reposted by Vicky Bennett

Mat Upton @matupton.bsky.social · 13/05/2025

Genomics & phenotype of 3 Cupriavidus strains from cystic fibrosis lung - great team with PhD student Sean Kelly, @vickyb-micro.bsky.social @kmudz.bsky.social & clinical collaborators. High quality genomes, MDR to CF drugs, susceptible to pip/tazo & cefotax academic.oup.com/jambio/artic...

academic.oup.com

Genomic insights and phenotypic characterization of three multidrug resistant Cupriavidus strains from the cystic fibrosis lung

AbstractAims. We aimed to investigate phenotypic and genomic traits of three Cupriavidus spp. isolates recovered from people with cystic fibrosis (PWCF). T

012

Reposted by Vicky Bennett

Sarah Cameron @sarah-kay3.bsky.social · 24/04/2025

Join us for 3 fun packed evenings at @bathbrewhouse to find out more about Our Bodies 👤🦵 Hear from researchers at the cutting edge of their fields, including @ella489.bsky.social and how she is making mini organs to study cancer! 🫀 🎟️ Tickets at pintofscience.co.uk/events/bath #pint25

001

Vicky Bennett @vickyb-micro.bsky.social · 24/04/2025

First publication with new group in Plymouth! @kmudz.bsky.social Highlights included the moment I discovered that Cupriavidus spp are in fact meant to have 2 chromosomes, so my 2 chromosome + 2 plasmid mega assembly wasn't a complete fail 💪 doi.org/10.1093/jamb...

doi.org

Genomic insights and phenotypic characterisation of three multidrug resistant Cupriavidus strains from the cystic fibrosis lung

AbstractAims. We aimed to investigate phenotypic and genomic traits of three Cupriavidus spp. isolates recovered from people with cystic fibrosis (PWCF). T

030

Vicky Bennett @vickyb-micro.bsky.social · 03/04/2025

www.the-microbiologist.com/features/a-c...

000